• Hjem
  • Podkaster
  • Toppliste
  1. Hjem
  2. Podkaster
  3. OncLive® On Air
  4. S11 Ep8: Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

S11 Ep8: Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

OncLive® On Air - En podkast av OncLive® On Air

Prøv Podimo gratis i hele 60! dager!

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

 Reklame
Podcast artwork

Dr Salgia discusses how he chooses between tepotinib and capmatinib in patients with stage IV NSCLC harboring MET exon 14 skipping mutations.

Visit the podcast's native language site

  • Alle podkaster
  • Episoder
  • Blogg
  • Om oss
  • Personvernpolicy
  • Hva er en podkast?
  • Hvordan lytte til en podkast?

© Podkast24.no 2025